Advertisement
Screener

Alamar Biosciences, Inc. (ALMR) Lessee, Operating Lease, Liability, Undiscounted Excess Amount

Alamar Biosciences, Inc. Lessee, Operating Lease, Liability, Undiscounted Excess Amount

Alamar Biosciences, Inc. (ALMR) had Lessee, Operating Lease, Liability, Undiscounted Excess Amount of $30.79 million as of 2026-06-30, per its 10-Q filed 2026-08-11.

Financial Statements › Notes › Leases

us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount · last filed 2026-08-11

  • 2026-06-30: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $30.79M.
  • 2026-03-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $16.40M.
Period endLessee, Operating Lease, Liability, Undiscounted Excess Amount
2026-06-30$30.79M
10-Q · filed 2026-08-11
2026-03-31$16.40M
10-Q · filed 2026-05-08

Similar stocks

Stock NameCountryMarket CapPE Ratio
Cytek Biosciences, Inc. (CTKB)United States$0.744B-7.15
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB)United States$0.491B-3.95
908 Devices Inc. (MASS)United States$0.476B-9.53
EyePoint, Inc. (EYPT)United States$0.314B-3.96
Quanterix Corp (QTRX)United States$0.150B-1.65
Nautilus Biotechnology, Inc. (NAUT)United States$0.129B-4.16
Seer, Inc. (SEER)United States$0.104B-1.34
Precipio, Inc. (PRPO)United States$0.043B-36.70
HARVARD BIOSCIENCE INC (HBIO)United States$0.037B-2.70
Bionano Genomics, Inc. (BNGO)United States$0.020B-0.42